FigureĀ 2.
PFS and OS for arm 1 (POM-DEX) vs arm 2 (IXA-POM-DEX). (A) PFS for all patients. (B) PFS for patients with standard-risk cytogenetic abnormalities. (C) PFS for patients with high-risk cytogenetic abnormalities. (D) OS. High-risk cytogenetic abnormalities were defined as the presence of at least 1 of the following: del(1p), del(17p), t(14;16), t(14;20), or gain/amp of 1q21.

PFS and OS for arm 1 (POM-DEX) vs arm 2 (IXA-POM-DEX). (A) PFS for all patients. (B) PFS for patients with standard-risk cytogenetic abnormalities. (C) PFS for patients with high-risk cytogenetic abnormalities. (D) OS. High-risk cytogenetic abnormalities were defined as the presence of at least 1 of the following: del(1p), del(17p), t(14;16), t(14;20), or gain/amp of 1q21.

Close Modal

or Create an Account

Close Modal
Close Modal